key: cord-0917507-qokitgb2
authors: Jung, Youn-Joo; Oh, Yunkyoung; Sujata, Purja; Jeong, Hyokeun; Kim, Eunyoung
title: Assessment of the reporting quality of randomised controlled trials related to the pharmacotherapy of COVID-19 based on the CONSORT 2010 checklist: A Systematic Review
date: 2022-01-06
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2021.12.016
sha: c92ff1a5176251ee62453520b66a8998a6097785
doc_id: 917507
cord_uid: qokitgb2

nan

To the Editor, 27 In a worldwide pandemic of Coronavirus disease 2019 (COVID-19), thousands of 28 randomised controlled trials (RCTs) on COVID-19 treatment have been conducted over 29 a short period, and 6,332 trials have been registered with clinicaltrials.gov to date [1] , 30 but research on the reporting quality of COVID-19 RCTs has been insufficient. 31 Incomplete reporting of RCTs can be harmful in clinical settings [2], so assessing the 32 reporting quality of RCTs related to pharmacotherapy of COVID-19 may be an 33 important way to identify effective treatments and end the pandemic. However, to our 34 knowledge, only one study has evaluated the reporting quality of RCTs related to December 2020, 87 RCTs were included in the final analysis ( Figure 1A , Table S1 ). 

National Institutes of Health United States National Library of Medicine [cited about statins and/or fibrates for diabetic retinopathy to the CONSORT checklist

Reporting quality of randomized controlled trials in restless legs syndrome based on the 155 CONSORT statement. Tremor Other Hyperkinet Mov (N Y)

Reporting 158 quality of randomized controlled trial abstracts among high-impact general medical 159 journals: a review and analysis

Assessing reporting 162 quality of randomized controlled trial abstracts in psychiatry: adherence to CONSORT 163 for abstracts: A systematic review

Quality of randomized controlled trials reporting in the treatment of adult 167 patients with high-grade gliomas